Business
Result of General Meeting, Director/PDMR Dealings
Result of General Meeting, Director/PDMR Dealings.
About this update from Oxford Biodynamics Plc
[{"type":"text","content":"\n \n \n THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN ARE RESTRICTED AND ARE NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR IN OR INTO ANY OTHER JURISDICTION WHERE TO DO SO WOULD BREACH ANY APPLICABLE LAW OR REGULATION.\n \n \n UNLESS OTHERWISE INDICATED, CAPITALISED TERMS IN THIS ANNOUNCEMENT HAVE THE MEANINGS GIVEN TO THEM IN THE DEFINITIONS SECTION OF THE CIRCULAR TO SHAREHOLDERS OF THE COMPANY ON 7 OCTOBER 2022.\n \n \n \n \n \n Oxford BioDynamics PLC\n \n \n (\"OBD\", the \"Company\" or together with its subsidiaries, the \"Group\")\n \n \n \n \n \n \n Result of General Meeting\n \n \n \n \n Director/PDMR Dealings\n \n \n \n Oxford, UK 27 October 2022\n Oxford BioDynamics Plc (AIM:OBD),\n a biotechnology company developing targeted clinical diagnostic tests for immune health based on the EpiSwitch® 3D genomics platform, announces that both of the resolutions proposed at the general meeting of the Company held earlier today were duly passed.\n \n \n Further to the passing of the resolutions at the general meeting of the Company held earlier today, application has been made for 17,223,750 new Ordinary Shares (comprising the VCT/EIS Shares to be issued pursuant to the Placing) to be admitted to trading on the AIM market (\"AIM\") of the London Stock Exchange (\"VCT/EIS Admission\"). Application has also been made for 29,137,056 new Ordinary Shares (comprising the General Placing Shares, Subscription Shares and Open Offer Shares to be issued pursuant to the Placing, Subscription and Open Offer) to be admitted to trading on AIM (\"General Admission\"). No further Ordinary Shares will be issued pursuant to the proposed Rump Placing announced on 25 October 2022.\n Accordingly, a total of £9.3 million has been conditionally raised via the Placing, Subscription and Open Offer.\n \n \n It is expected that VCT/EIS Admission will take place, and trading in the VCT/EIS Shares will commence, at 8.00 a.m. on 28 October 2022 and that General Admission will take place, and trading in the General Placing Shares, Subscription Shares and Open Offer Shares will commence at 8.00 a.m. on 31 October 2022.\n \n \n Following VCT/EIS Admission, the Company's issued ordinary...